赛诺菲、Formation Bio 和 OpenAI 合作开发人工智能药物开发软件。 Sanofi, Formation Bio, and OpenAI collaborate to create AI-powered drug development software.

赛诺菲、Formation Bio 和 OpenAI 宣布建立一流的 AI 合作，以构建 AI 驱动的软件，旨在加速药物开发并更有效地为患者带来新药。 Sanofi, Formation Bio and OpenAI announced a first-in-class AI collaboration to build AI-powered software, aiming to accelerate drug development and bring new medicines to patients more efficiently. 两家公司将结合数据、软件和调整模型，在整个药物开发生命周期中创建定制解决方案。 The companies will combine data, software and tuned models to create custom solutions across the drug development lifecycle. 赛诺菲将利用此次合作关系提供专有数据访问权，致力于成为第一家大规模采用人工智能的生物制药公司。 Sanofi will leverage this partnership to provide access to proprietary data, as it aims to become the first biopharma company powered by AI at scale.